Invokana Lawsuit

The Food and Drug Administration has issued warnings about SGLT2 inhibitors like Invokana concerning an increased risk of Diabetic Ketoacidosis (DKA), kidney injury, and amputation of leg, foot, or toes.  Other studies have raised concerns about cardiovascular injuries, such as heart attack or stroke.  If you or a loved one have been harmed after taking Invokana, you may be eligible to file an Invokana lawsuit.

Should I talk to a lawyer about the experience I had with the drug Invokana?

invokanaIf you or a loved one used the type 2 diabetes medication Invokana, you might be eligible for financial compensation. Some Invokana users have developed diabetic ketoacidosis and suffered other side effects after using the drug.

Invokana (canagliflozin) is an SGLT2 inhibitor, which is a type of medication that works by lowering blood glucose levels. It does this by encouraging higher amounts of sugar to be released through urine.

Though the medication does help control blood sugar levels, it triggers a number of other side effects, many of which are severe. Some Invokana users experienced cardiovascular issues including heart attacks and strokes, as well as diabetic ketoacidosis and kidney health issues. There is also evidence use of Invokana might be linked to an increased risk for limb amputation.

For some, the use of Invokana triggered side effects so severe they needed hospitalization. Others suffered permanent disability.

In response to these devastating medical emergencies, many Invokana users have opted to take legal action against the makers of the drug. Both Janssen Pharmaceuticals and its parent company, Johnson & Johnson, allegedly failed to warn consumers and doctors about the risks linked to their drug.

Side Effects of Invokana

A number of different side effects are linked to Invokana. These side effects ranges from mild to severe, and include:

  • Kidney injury and kidney failure
  • Urinary tract infection
  • Cardiovascular problems including heart attacks
  • Diabetic ketoacidosis
  • Amputation

Diabetics face an increased risk for vascular problems, which in some cases can lead to the need for amputation. Clinical trials have shown that diabetics treating their disease with Invokana face an even higher risk.

Though researchers are not yet sure what causes the increase in risk, they believe it’s linked to the way in which the drug affects the vascular system. When not enough oxygen and nutrients reach the extremities, it can cause cell death. It’s also possible for minor injuries to develop into serious infections. In both cases, amputation is needed to stop the spread of the problem. Many believe Invokana users have an elevated risk for leg, foot, and especially toe amputation.

If you experience any unusual symptoms in your extremities, or you have any symptoms that could be related to heart or kidney health issues, you should seek medical attention immediately.

Do You Have an Invokana Lawsuit?

Invokana users and their families might have a right to take legal action against Janssen and Johnson & Johnson if their use of the drug caused injuries. Current lawsuits against the drug makers allege the companies were aware of the risks and failed to warn doctors and consumers. Users of the drug claim if they had known of the risks they would have opted for a different course of treatment.

Those who were injured or lost loved ones after use of Invokana to treat type 2 diabetes could be eligible for financial compensation for medical treatment, lost wages, and pain and suffering. Should it be proven the drug makers were aware of the risks, those affected might also be entitled to punitive damages.

There are currently several individual lawsuits regarding Invokana in courts across the country. If enough people take action, the cases might be combined into multi-district litigation, making the process of resolving the matter easier for everyone involved.

Since the FDA issued its warning concerning Invokana, more users have come forward with claims. It is expected additional lawsuits will be filed as more and more people make the connection between their health problems and their use of Invokana.

Have you experienced any of the following after using Invokana?

  • Stroke
  • Kidney injuries
  • Diabetic ketoacidosis
  • Amputation
  • Other side effects

You might be eligible for compensation. Contact us today to learn more.

View Sources
  1. Brooks, M., (15 May 2015), SGLT2 inhibitor diabetes drugs may cause ketoacidosis: FDA, Medscape, accessed on 19 May 2016 http://www.medscape.com/viewarticle/844754
  2. Cefalu, W. et al, (2015), SGLT2 Inhibitors: The Latest “New Kids on the Block”!, Diabetes Care, accessed on 19 May 2016 http://care.diabetesjournals.org/content/38/3/352.full
  3. Food and Drug Administration, (15 May 2015), Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood, U.S. Food and Drug Administration, accessed on 19 May 2015 http://www.fda.gov/Drugs/DrugSafety/ucm475463.htm
  4. Drugs.com, Invokana Prescribing Information, Drugs.com, Accessed on 08 June 2015 http://www.drugs.com/pro/invokana.html
  5. Food and Drug Administration (15 May 2015), FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood, U.S. Food and Drug Administration, Accessed on 08 June 2015 http://www.fda.gov/Drugs/DrugSafety/ucm446845.htm
  6. Food and Drug Administration, (04 December 2015), Drug Safety Communication: FDA revised labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infection, U.S. Food and Drug Administration, U.S. Food and Drug Administration, accessed on 19 May 2015 http://www.fda.gov/Drugs/DrugSafety/ucm446845.htm
  7. Food and Drug Administration, (18 May 2016), Drug Safety Communication: Interim clinical trial results find increased risk of leg and foot amputations, mostly affecting the toes, with the diabetes medicine canagliflozin (Invokana, Invokamet); FDA to investigate, U.S. Food and Drug Administration, accessed on 19 May 2015 http://www.fda.gov/Drugs/DrugSafety/ucm500965.htm
  8. ISMP, (06 May 2015), Questions about Canagliflozin (INVOKANA), Quarter Watch, 2., Institute for Safe Medication Practices, accessed on 19 May 2016 http://www.ismp.org/QuarterWatch/pdfs/2014Q2.pdf
  9. Mayo Clinic, (23 October 2013). Diabetic ketoacidosis, Mayo Clinic, accessed on 19 May 2016 http://www.mayoclinic.org/diseases-conditions/diabetic-ketoacidosis/basics/definition/con-20026470
  10. Nainggolan, Lisa, (15 April 2016), EMA Probes Link with Diabetes Drug Canagliflozin, Toe Amputation, Medscape Medical News, accessed on 19 May 2016 http://www.medscape.com/viewarticle/862009
  11. National Library of Medicine, (2016), Invokana-canagliflozin tablet prescribing information, U.S. National Library of Medicine, accessed on 19 May 2016 http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9057d3b-b104-4f09-8a61-c61ef9d4a3f3